Biotricity Analyst Ratings
Biotricity Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/20/2023 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 07/05/2023 | 316.67% | HC Wainwright & Co. | $2 → $4 | Reiterates | Buy → Buy |
| 02/15/2023 | 108.33% | HC Wainwright & Co. | → $2 | Reiterates | → Buy |
| 07/15/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 07/15/2022 | 108.33% | HC Wainwright & Co. | $6 → $2 | Maintains | Buy |
| 03/07/2022 | 420.83% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 11/23/2021 | 525% | HC Wainwright & Co. | → $6 | Initiates Coverage On | → Buy |
| 07/01/2021 | 629.17% | Northland Capital Markets | → $7 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/20/2023 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 07/05/2023 | 316.67% | HC Wainwright & Co. | 2 美元 → 4 美元 | 重申 | 購買 → 購買 |
| 02/15/2023 | 108.33% | HC Wainwright & Co. | → 2 美元 | 重申 | → 購買 |
| 07/15/2022 | — | Maxim 集團 | 降級 | 買入 → 持有 | |
| 07/15/2022 | 108.33% | HC Wainwright & Co. | 6 美元 → 2 美元 | 維護 | 買 |
| 03/07/2022 | 420.83% | 湖街 | → 5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/23/2021 | 525% | HC Wainwright & Co. | → 6 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 07/01/2021 | 629.17% | 北國資本市場 | → 7 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for Biotricity (BTCY)?
Biotricity（BTCY）的目標價格是多少？
The latest price target for Biotricity (NASDAQ: BTCY) was reported by HC Wainwright & Co. on November 20, 2023. The analyst firm set a price target for $0.00 expecting BTCY to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月20日公佈了Biotricity（納斯達克股票代碼：BTCY）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計BTCY將在12個月內跌至12個月內（可能下跌-100.00％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Biotricity (BTCY)?
Biotricity（BTCY）的最新分析師評級是多少？
The latest analyst rating for Biotricity (NASDAQ: BTCY) was provided by HC Wainwright & Co., and Biotricity downgraded their neutral rating.
HC Wainwright & Co. 對Biotricity（納斯達克股票代碼：BTCY）的最新分析師評級由HC Wainwright & Co. 提供，Biotricity下調了中性評級。
When is the next analyst rating going to be posted or updated for Biotricity (BTCY)?
Biotricity（BTCY）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biotricity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biotricity was filed on November 20, 2023 so you should expect the next rating to be made available sometime around November 20, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Biotricity的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Biotricity的最新評級是在2023年11月20日發佈的，因此您應該預計下一個評級將在2024年11月20日左右公佈。
Is the Analyst Rating Biotricity (BTCY) correct?
分析師評級 Biotricity（BTCY）是否正確？
While ratings are subjective and will change, the latest Biotricity (BTCY) rating was a downgraded with a price target of $0.00 to $0.00. The current price Biotricity (BTCY) is trading at is $0.96, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Biotricity（BTCY）評級已下調，目標股價爲0.00美元至0.00美元。Biotricity（BTCY）目前的交易價格爲0.96美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。